Physiomics Plc (LON:PYC – Get Free Report) traded up 20% during mid-day trading on Wednesday . The company traded as high as GBX 0.97 ($0.01) and last traded at GBX 0.93 ($0.01). 6,918,706 shares traded hands during mid-day trading, an increase of 65% from the average session volume of 4,186,623 shares. The stock had previously closed at GBX 0.78 ($0.01).
Physiomics Trading Down 1.0 %
The stock’s 50-day simple moving average is GBX 0.71 and its 200-day simple moving average is GBX 0.72. The stock has a market cap of £1.66 million, a price-to-earnings ratio of -13.83 and a beta of 1.69.
Insider Activity at Physiomics
In other news, insider Peter Sargent bought 459,090 shares of the firm’s stock in a transaction on Thursday, November 7th. The shares were purchased at an average cost of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,648.95). 4.18% of the stock is currently owned by corporate insiders.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Featured Stories
- Five stocks we like better than Physiomics
- What is a support level?
- 3 Stocks Leveraging NVIDIA’s Strength for Profits
- CD Calculator: Certificate of Deposit Calculator
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
- What is the S&P 500 and How It is Distinct from Other Indexes
- Unstoppable Yields: 3 Blue-Chip Stocks to Maximize Returns
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
